Rahul Sharma (Editor)

Harris and Harris Group

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Public

Industry
  
Venture Capital

Number of employees
  
11

Founder
  
Charles Harris

Traded as
  
NASDAQ: TINY

Products
  
Asset Management

Website
  
www.hhvc.com

Founded
  
1981

Harris & Harris Group wwwhhvccomwpcontentthemesharristhemeimages

Stock price
  
TINY (NASDAQ) US$ 1.36 +0.04 (+3.03%)16 Mar, 4:00 PM GMT-4 - Disclaimer

Headquarters
  
New York City, New York, United States

Profiles

Harris & Harris Group is a publicly traded venture capital firm which invests in nanotechnology companies. Harris & Harris Group was incorporated in 1981, and it completed an initial public offering (IPO) in 1983.

Throughout its history, Harris & Harris Group made over 90 investments. Over 60 of these investments have generated realized returns of approximately $160 million on cumulative invested capital of approximately $92 million.

In 2011, five of Harris & Harris Group’s portfolio companies completed liquidity events including two IPOs (Solazyme and NeoPhotonics) and three sale transactions (BioVex Group to Amgen, Innovalight to DuPont and Crystal IS to Asahi Kasei).

In July 2013, portfolio company Xradia was acquired by Carl Zeiss.

Other investments include Nantero, Nanosys, Kovio, and Ensemble Therapeutics.

Restatement

On March 15, 2005, management concluded that the previously issued consolidated financial statements for the year ended December 31, 2002 should no longer be relied upon was restated because of computational errors in Consolidated Statements of Operations.

References

Harris & Harris Group Wikipedia